Galidesivir approved for treatment use in in Ebola epidemic
Filed with ASX · · 8 pages · English
Island Pharmaceuticals Ltd on 6ix
In the deck
Earlier from Island Pharmaceuticals
- Pause in Trading
- Singapore Patent Expands Island's ISLA 101 Viral Protection
- FDA Grants Orphan Designation for Galidesivir in Marburg
- Investor Presentation - Asia Dengue Summit
- Investor presentation
Later from Island Pharmaceuticals
- Investor Presentation - Ebola Clinical Program
- Texas Biomed SOW accelerates pivotal FDA pathway
- Quarterly Appendix 4C and Activities Report
- Application for quotation of securities - ILA
- Cleansing Notice
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals